Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
A New Method to Segment the Multiple Sclerosis Lesions on Brain Magnetic Resonance Images.
IgE-mediated hypersensitivity reaction and desensitization to glatiramer acetate in a pediatric patient.
Abnormal fatty acid pattern in the superior temporal gyrus distinguishes bipolar disorder from major depression and schizophrenia and resembles multiple sclerosis.
Burden and cost of neurological diseases: a European North-South comparison.
Antibody patterns vary arbitrarily between cerebrospinal fluid and aqueous humor of the individual multiple sclerosis patient: Specificity-independent pathological B cell function.
Multiple sclerosis in children and adolescents. An important differential diagnosis of acute neurological disease.
Is electroconvulsive therapy safe in multiple sclerosis?
A simple procedure for the extraction of DNA from long-term formalin-preserved brain tissues for the detection of EBV by PCR.
Are PrP(C)s involved in some human myelin diseases? Relating experimental studies to human pathology.
Signal transduction and epigenetic mechanisms in the control of microglia activation during neuroinflammation.
Neurostereology protocol for unbiased quantification of neuronal injury and neurodegeneration.
Quetiapine Inhibits Microglial Activation by Neutralizing Abnormal STIM1-Mediated Intercellular Calcium Homeostasis and Promotes Myelin Repair in a Cuprizone-Induced Mouse Model of Demyelination.
Depression in multiple sclerosis: effect of brain derived neurotrophic factor Val66Met polymorphism and disease perception.
Crowdsourced research: Many hands make tight work.
Characteristics of Patients with Relapsing Remitting Multiple Sclerosis Taking once Daily Teriflunomide Tablets in the United States.
Epidemiology and Current Treatment of Neuromyelitis Optica: A Systematic Review.
Efficacy and safety of onabotulinumtoxinA therapy are sustained over 4 years of treatment in patients with neurogenic detrusor overactivity: Final results of a long-term extension study.
Multiple sclerosis-induced neuropathic pain: pharmacological management and pathophysiological insights from rodent EAE models.
Assessment of Autonomic Dysfunction in Childhood Guillain-Barré Syndrome.
Neuropsychiatric side-effects of interferon-alpha treatment: pathophysiology and therapeutic options.
Whom to Target for Falls-Prevention Trials: Recommendations from the International MS Falls Prevention Research Network.
Distress improves after mindfulness training for progressive MS: A pilot randomised trial.
Long-term safety of fingolimod: Interim evaluation of data from the longterms trial.
Immunodetection of oligoclonal bands in serum and CSF of Multiple Sclerosis patients.
Haplotype-based approach to known MS-associated regions increases the amount of explained risk.
Pages
« first
‹ previous
…
684
685
686
687
688
689
690
691
692
…
next ›
last »